Mechanism of Action: Reduction Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Reduction Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 091684-001 | Oct 31, 2017 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Exela Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 204797-001 | Apr 15, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Exela Pharma | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 205643-001 | Nov 1, 2023 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 073664-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Eugia Pharma | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 207358-001 | Feb 29, 2016 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hospira | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 074037-001 | Aug 30, 1994 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Glenmark Pharms Inc | ACETYLCYSTEINE | acetylcysteine | INJECTABLE;INTRAVENOUS | 213693-001 | Feb 3, 2022 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
